Allogeneic EBV-specific T-cell product | EBV antigen specificity (HLA restriction) |
TIG-001 | LMP2 (SSCSSCPLSK/A*11:01, TYGPVFMCL/A*24:02) and EBNA1 (FVYGGSKTSL/C*03:04) |
TIG-002 | LMP1 (YLLEMLWRL/A*02:01, YLQQNWWTL/A*02:01); LMP2 (FLYALALLL/A*02:01, IEDPPFNSL/B*40:01); EBNA1 (FVYGGSKTSL/C*03:04) |
TIG-003 | LMP1 (IALYLQQNW/B*58:01); LMP2 (IEDPPFNSL/B*40:01, MSNTLLSAW/B*58:01); EBNA1 (FVYGGSKTSL/C*03:04) |
TIG-004 | EBNA1 (RPQKRPSCIGC /B*07:02) |
TIG-005 | LMP1 (YLLEMLWRL/A*02:01); LMP2 (FLYALALLL/A*02:01, PYLFWLAAI/A*23:01) |
TIG-006 | LMP2 (SSCSSCPLSK/A*11:01) |
EBNA1, EBV-encoded nuclear antigen 1; EBV, Epstein-Barr virus; HLA, human leukocyte antigen; LMP1, latent membrane protein 1; LMP2, latent membrane protein 2.